Theophylline and cisplatin synergize in down regulation of BCL-2 induction of apoptosis in human granulosa cells transformed by a mutated p53 (p53 val135) and Ha-ras oncogene.

International journal of oncology

Volumn 17, Issue 2, 2000, Pages 227-235

  Yoshida, Y ^a   Hosokawa, K ^a   Dantes, A ^a   Tajima, K ^a   Kotsuji, F ^a   Amsterdam, A ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PHOSPHODIESTERASE INHIBITOR; PROTEIN BCL 2; PROTEIN P53; THEOPHYLLINE; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; DRUG COMBINATION; DRUG EFFECT; FEMALE; GRANULOSA CELL; HUMAN; METABOLISM; ONCOGENE RAS; OVARY TUMOR; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; DRUG THERAPY, COMBINATION; FEMALE; GENES, RAS; GRANULOSA CELLS; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PHOSPHODIESTERASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; THEOPHYLLINE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034242313     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.17.2.227     Document Type: Article

References (0)